Skip to content
BioSpace· Gabrielle Masson·· 3 hours agoPickScore40

Biotech IPOs raise $7.5B as sector’s performance rally flattens

In brief

Biotech IPOs raised $7.5 billion across 22 offerings in the first three quarters of 2026, according to J.P. Morgan. The XBI fell less than 1% in the third quarter as the sector's rally flattened. Parabilis Medicines' summer debut raised $670 million, the largest IPO in biotech history, and at least 31 biotechs had gone public as of Oct. 26.

Why it matters

Quantifies 2026 biotech IPO activity and the sector's flattening rally.

Source: BioSpace · biospace.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.